We began by quantitating the distribution of T cell subsets in the 3 HPB cancer types, to identify whether there may be distinct features in CD4+ and CD8+ T cell differentiation, activation, trafficking, phenotype, co-inhibitory and co-stimulatory checkpoint molecules in the tumor microenvironment (TME) using single marker analysis. The gene discussed is CD4; the disease is cancer.